WuXi’s Facility in China Receives Brazilian GMP Certification for Dengue Vaccine Manufacturing

CDMO WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, reports that its drug substance facility (MFG23) located in Suzhou, China, has received GMP certification from Brazil’s Agência Nacional de Vigilância Sanitária (ANVISA). The facility provides integrated manufacturing services for Instituto Butantan’s dengue vaccine (Butantan-DV) production project.

“The GMP certification of our DS facility, our second certification from ANVISA, represents a pivotal step in advancing our dengue vaccine project with Instituto Butantan and establishing a solid foundation to deliver on our shared commitment to expand access to high-quality dengue vaccines,” said Jian Dong, CEO of WuXi Vaccines. “Adhered to premier quality standards and powered by our integrated solutions and technologies, we remain committed to driving greater access to safe, effective, and affordable vaccines worldwide.”

Based on the commercial manufacturing agreement with Instituto Butantan and Fundação Butantan, WuXi Vaccines will provide end-to-end services, including drug substance and drug product manufacturing and quality control for the 5-dose dengue vaccine, according to Dong. The partnership plans to rapidly scale up vaccine capacity, aiming to deliver millions of doses to shield Brazil’s population from dengue. In November 2025, the single-dose Butantan-DV received ANVISA approval for use with individuals aged 12 to 59.

The post WuXi’s Facility in China Receives Brazilian GMP Certification for Dengue Vaccine Manufacturing appeared first on GEN – Genetic Engineering and Biotechnology News.

Trump says latest medical exam went ‘PERFECTLY’

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

Good morning. You know that one Emily Dickinson poem? “Because I could not stop for Death – / He kindly stopped for me – / The Carriage held but just Ourselves – / And Immortality.” I’d love to hear a longevity enthusiast’s close reading. In the meantime, scroll down for a great story from Sarah Todd on the movement’s latest death-defying initiatives.

Read the rest…

STAT+: ‘Are we just going to give up and die like every other generation?’

BERKELEY, Calif. — On a sunny Thursday morning, around 100 people sat on folding chairs beneath a lawn tent preparing to do a mass blood draw. Standing onstage with a tangle of morning glories as his backdrop, Robby Wade, CEO of at-home testing company Rythm Health, warned that the process might be a little chaotic given the size of the crowd. 

Wade explained how to activate the heating pads by popping a small silver coin, prompting a chorus of admiring oohs from the audience as rays of warming crystallized gel spread like the sun. Within a few minutes, everyone, me included, had matching stick-on Tasso devices trickling blood from our upper arms into test tubes that promised to give insights into the health of our hormones, metabolisms, various organs, and biological age.

“It’s like Theranos, but it works,” said the gentleman sitting in front of me, who had recently given a talk on bodyoids — creating headless sacs of organs to replace aging people’s failing hearts and kidneys.

It was the first day of Vitalist Bay, a longevity conference-slash-festival launched last year that brings together founders, investors, biohackers, researchers, and the generally death-averse to discuss how to forestall, or even beat, our demise. Held at an event space (and rationalist AI doomer hub) called Lighthaven, the grounds were dotted with well-padded wicker patio furniture and taffy-pink rose bushes. Along with hearing talks on topics like cryopreservation and delaying menopause, attendees might opt to attend a workshop on longevity therapeutics led by a co-founder of BioAge Labs, drop by a Krav Maga lesson, or take a sound bath. The mood was buoyant, the Oura rings ubiquitous, the stakes existential. 

“Are we just going to give up and die like every other generation?” Adam Gries, co-founder of the conference and larger Vitalist movement, asked in his opening remarks. 

Giving up and dying had been basically my plan, though hopefully not for a long time. Perhaps that was because I hadn’t given enough thought, as the people at Vitalist Bay had, to considering the alternatives. As the field works to make the showdown against death and aging mainstream, the longevity community is now in the midst of shifting from “a movement to really more of an industry,” said Christine Peterson, co-founder of the Foresight Institute, which focuses on research on longevity and nanotechnology. 

Continue to STAT+ to read the full story…

STAT+: How Stanford patients help expose ‘fault lines’ in health AI adoption

At Stanford University, it’s easy to get carried away with technology. The computer mouse was invented there. So was Google. And now, it’s pumping out a myriad of tools for artificial intelligence in health care.

But for the last year and a half, Stanford’s hospital has been asking patients about new AI tools before they roll them out. 

Eric Gries is one of those people, handpicked by Stanford as part of a “patient panel.” Gries was the caregiver for his wife while she was first on a left ventricular assist device (LVAD), then had a heart transplant. He later became the temporary caregiver for his brother-in-law when he also had a heart transplant. 

Continue to STAT+ to read the full story…

Opinion: Sen. Dick Durbin: Trump is letting Big Tobacco target children

When I was 14 years old, I lost my father to lung cancer. He was 53 and smoked two packs of Camels a day. I have made it a priority during my time in Congress to champion policies that help spare others from this tragedy.

Smoking rates have hit record lows. In 1988, I passed legislation that banned smoking on domestic flights, marking the start of cigarettes disappearing from public spaces.

Read the rest…